Author details

Full Name

Sarah Barelier

Affiliation

CNRS, Aix-Marseille University

ORCID

Career Start Year

2009

Papers

H Index

Expertise

CM4AI Collaborator

Nevan J Krogan (CM4AI)

PMID	Paper Title	Journal Title	Published Year
36197115	Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M.â¿¿tuberculosis.	FEBS J	2023
37192550	Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases.	Eur J Med Chem	2023
36206736	The long-awaited structure of human fucosidase FucA1 opens novel avenues for the treatment of fucosidosis.	Structure	2022
35398351	Molecular basis for substrate recognition and septum cleavage by AtlA, the major N-acetylglucosaminidase of Enterococcus faecalis.	J Biol Chem	2022
25981045	Lineage-Specific Viral Hijacking of Non-canonical E3Â Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity.	Cell Rep	2015
26421501	The Recognition of Identical Ligands by Unrelated Proteins.	ACS Chem Biol	2015
24791931	Substrate deconstruction and the nonadditivity of enzyme recognition.	J Am Chem Soc	2014
24807704	Increasing chemical space coverage by combining empirical and computational fragment screens.	ACS Chem Biol	2014
23874896	Roles for ordered and bulk solvent in ligand recognition and docking in two related cavities.	PLoS One	2013
23043117	Fragment-guided design of subnanomolar Î²-lactamase inhibitors active in vivo.	Proc Natl Acad Sci U S A	2012
21411360	Ligand specificity, privileged substructures and protein druggability from fragment-based screening.	Curr Opin Chem Biol	2011
21771585	Aspartate 458 of human glutathione synthetase is important for cooperativity and active site structure.	Biochem Biophys Res Commun	2011
20305821	Discovery of fragment molecules that bind the human peroxiredoxin 5 active site.	PLoS One	2010
20800579	The role of the glycine triad in human glutathione synthetase.	Biochem Biophys Res Commun	2010
20575554	Ligand specificity in fragment-based drug design.	J Med Chem	2010
20192224	Fragment-based deconstruction of Bcl-xL inhibitors.	J Med Chem	2010
19118006	Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.	Cancer Res	2009

1 - 17 of 17

Paola Bisignano

Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai

Career Start Year 2010

Number of shared co-authors 1

Nir London

The Weizmann Institute of Science

Career Start Year 2007

Number of shared co-authors 4

Guillaume Poncet-Montange

Center for the Development of Therapeutics, Broad Institute of MIT & Harvard

Career Start Year 2007

Number of shared co-authors 1

Jacob D Durrant

University of Pittsburgh

Career Start Year 2006

Number of shared co-authors 0

Magdalena Korczynska

Department of Pharmaceutical Chemistry, University of California san francisco

Career Start Year 2005

Number of shared co-authors 5

Priyadarshini Jaishankar

Department of Pharmaceutical Chemistry, University of California san francisco

Career Start Year 2005

Number of shared co-authors 4

Chakrapani Kalyanaraman

Department of Pharmaceutical Chemistry, University of California san francisco

Career Start Year 2002

Number of shared co-authors 3

Gerald H Lushington

Inc. 16 Dekalb Pike

Career Start Year 2002

Number of shared co-authors 0

Matthew P Jacobson

Department of Pharmaceutical Chemistry, University of California san francisco

Career Start Year 1999

Number of shared co-authors 12

Heather A Carlson

University of Michigan ann arbor

Career Start Year 1999

Number of shared co-authors 0

David R Hall

Diamond Light Source Ltd, Harwell Science & Innovation Campus

Career Start Year 1998

Number of shared co-authors 1

Eric Feyfant

Schrodinger Inc.

Career Start Year 1997

Number of shared co-authors 0

Adam R Renslo

Department of Pharmaceutical Chemistry, University of California san francisco

Career Start Year 1997

Number of shared co-authors 7

Dmitri Beglov

Boston University

Career Start Year 1997

Number of shared co-authors 1

Rodrigo J Carbajo

Oncology R&D

Career Start Year 1997

Number of shared co-authors 0

Peter Kolb

Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg

Career Start Year 1996

Number of shared co-authors 4

Roberto Sanchez

Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai

Career Start Year 1996

Number of shared co-authors 0

Andrew L Hopkins

University of Dundee

Career Start Year 1995

Number of shared co-authors 0

Cristian G Bologa

University of New Mexico School of Medicine

Career Start Year 1995

Number of shared co-authors 1

Tudor I Oprea

Expert Systems Inc.

Career Start Year 1993

Number of shared co-authors 2

John P Overington

Institute of Cardiovascular Science, University College London

Career Start Year 1988

Number of shared co-authors 1

Gerhard Klebe

Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg

Career Start Year 1988

Number of shared co-authors 3

Herman W T van Vlijmen

Leiden Academic Centre for Drug Research (LACDR), Leiden University

Career Start Year 1988

Number of shared co-authors 0

Diane Joseph-McCarthy

Boston University

Career Start Year 1987

Number of shared co-authors 1

Andrew R Leach

European Bioinformatics Institute (EMBL-EBI)

Career Start Year 1987

Number of shared co-authors 3

Antonio Macchiarulo

Department of Pharmaceutical Sciences, University of Perugia

Career Start Year 1986

Number of shared co-authors 0

Christophe L M J Verlinde

University of Washington

Career Start Year 1984

Number of shared co-authors 0

Ruben Abagyan

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California

Career Start Year 1981

Number of shared co-authors 1

Christine Humblet

Lilly Research Laboratories

Career Start Year 1977

Number of shared co-authors 0

Jens Meiler

Vanderbilt University

Career Start Year 1954

Number of shared co-authors 0

row(s) 1 - 30 of 30

Brian K Shoichet

Department of Pharmaceutical Chemistry, University of California san francisco

Co-authored papers 5

Kathleen E Franks-Skiba

University of California, USA Quantitative Biosciences Institute (QBI) san francisco

Co-authored papers 1

David J Stanley

Department of Pharmaceutical Chemistry, University of California san francisco

Co-authored papers 1

Nevan J Krogan (CM4AI)

University of California San Francisco

Co-authored papers 1

Jeffrey R Johnson

Gladstone Institutes

Co-authored papers 1

Nicole Mietrach

Institute for Molecular Infection Biology, Julius Maximilians University Wurzburg

Co-authored papers 1

Stef??n R J??nsson

Institute for Experimental Pathology, University of Iceland

Co-authored papers 1

William L Brown

University of Minnesota

Co-authored papers 1

Judd F Hultquist

Northwestern University Feinberg School of Medicine

Co-authored papers 1

Jennifer M Binning

H. Lee Moffitt Cancer Center and Research Institute

Co-authored papers 1

Adalbjorg Adalbjornsd??ttir

Institute for Experimental Pathology, University of Iceland

Co-authored papers 1

John J Irwin

Department of Pharmaceutical Chemistry, University of California san francisco

Co-authored papers 1

Karen N Allen

Boston University

Co-authored papers 1

Joshua Kane

University of California, USA Quantitative Biosciences Institute (QBI) san francisco

Co-authored papers 1

Tasha Johnson

Quantitative Biosciences Institute (QBI), University of California san francisco

Co-authored papers 1

John D Gross

Department of Pharmaceutical Chemistry, University of California san francisco

Co-authored papers 1

Frank M Raushel

Texas A&M University, College Station

Co-authored papers 1

Daniel S Hitchcock

Broad Institute of MIT and Harvard

Co-authored papers 1

James S Fraser

University of California san francisco

Co-authored papers 1

Steven C Almo

Albert Einstein College of Medicine

Co-authored papers 1

Matthew J O'Meara

University of Michigan ann arbor

Co-authored papers 1

Ming Li

Department of Cancer Research Institute, University of South Australia

Co-authored papers 1

Valgerdur Andr??sd??ttir

Institute for Experimental Pathology, Biomedical Center, University of Iceland

Co-authored papers 1

H??r??ur Ingi Gunnarsson

Center for Molecular Medicine, Karolinska Institutet

Co-authored papers 1

Billy W Newton

University of California San Francisco

Co-authored papers 1

Reuben S Harris

University of Texas Health San Antonio

Co-authored papers 1

1 - 26

Author Details

Column Actions

Recommended Authors

Collaborators